Ratchanee Hongprayoon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ratchanee Hongprayoon has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Kawin Punyokun
Center for Agricultural Biotechnology, Kasetsart University, Thailand
2 shared publicationsTheerapol Sirinarumitr
Department of Veterinary Pathology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, Thailand
2 shared publicationsManeerat Koohapitagtam
Center for Agricultural Biotechnology, Kasetsart University, Nakhon Pathom, 73140, Thailand
1 shared publicationPrapansak Srisapoome
Department of Aquaculture Faculty of Fisheries Kasetsart University Bangkok Thailand
1 shared publication- Prapansak Srisapoome
Kasetsart University
1 shared publication Sirikul Wasee
Kasetsart University
1 shared publication
Latest Publications
- 30 October 2019
- Published by Springer Nature in Journal of Plant Pathology
- Vol. 102 (2) , 327-333
Monoclonal antibody-based diagnostic assays for pepper mild mottle virus
- 30 October 2019
- Published by Springer Nature in Journal of Plant Pathology
- Vol. 102 (2) , 327-333
Monoclonal antibody-based diagnostic assays for pepper mild mottle virus
- Open Access
- 12 October 2015
- Published by Canadian Center of Science and Education in Modern Applied Science
- Vol. 9 (12) , 110
Influence of Chitosan-Alginate Microcapsules Containing Anti-Vibrio Harveyi IgY in the Gastrointestinal Tract Simulation
Egg yolk immunoglobulin (IgY) is an alternative treatment for the prevention of gastrointestinal infections in pigs, cows, chickens and fish. In our previous report, we preliminarily proved that anti-V. harveyi IgY had effective potential to control luminous disease in black tiger shrimp. However,IgY activity may be reduced or destroyed by gastric conditions, particularly low pH and digestive enzymes. Therefore, it is necessary to find an effective method to preserve the therapeutic function of IgY antibodies during gastric passage. Chitosan-alginate microcapsules have been developed to protect IgY from gastric inactivation. The processing factors included different forms of chitosan and alginate, while a CaCl2 concentration and encapsulation medium was investigated. The optimum results were obtained under the following conditions: High Mw chitosan concentration 0.2% (w/v), medium viscosity alginate concentration 2% (w/v), CaCl2 concentration 0.5% (w/v). The stability of IgY in simulated gastric fluid (SGF, pH 1.2) was greatly improved by encapsulation in chitosan-alginate microcapsules, and retained greater than 90% activity after 2 h exposure to SGF. Less than 10% IgY was released upon the microcapsules’ exposure to SGF for 2 h, and more than 80% IgY was released upon the microcapsules’ exposure to simulated intestinal fluid (SIF, pH 6.8) for 16 h.
- 12 October 2015
- Published by Canadian Center of Science and Education in Modern Applied Science
- Vol. 9 (12) , 110
Open AccessInfluence of Chitosan-Alginate Microcapsules Containing Anti-Vibrio Harveyi IgY in the Gastrointestinal Tract Simulation
Egg yolk immunoglobulin (IgY) is an alternative treatment for the prevention of gastrointestinal infections in pigs, cows, chickens and fish. In our previous report, we preliminarily proved that anti-V. harveyi IgY had effective potential to control luminous disease in black tiger shrimp. However,IgY activity may be reduced or destroyed by gastric conditions, particularly low pH and digestive enzymes. Therefore, it is necessary to find an effective method to preserve the therapeutic function of IgY antibodies during gastric passage. Chitosan-alginate microcapsules have been developed to protect IgY from gastric inactivation. The processing factors included different forms of chitosan and alginate, while a CaCl2 concentration and encapsulation medium was investigated. The optimum results were obtained under the following conditions: High Mw chitosan concentration 0.2% (w/v), medium viscosity alginate concentration 2% (w/v), CaCl2 concentration 0.5% (w/v). The stability of IgY in simulated gastric fluid (SGF, pH 1.2) was greatly improved by encapsulation in chitosan-alginate microcapsules, and retained greater than 90% activity after 2 h exposure to SGF. Less than 10% IgY was released upon the microcapsules’ exposure to SGF for 2 h, and more than 80% IgY was released upon the microcapsules’ exposure to simulated intestinal fluid (SIF, pH 6.8) for 16 h.
- Open Access
- 1 September 2013
- Published by Taylor & Francis in Food and Agricultural Immunology
- Vol. 24 (3) , 279-294
The production of anti-Vibrio harveyiegg yolk immunoglobulin and evaluation of its stability and neutralisation efficacy
In order to replace the antibiotic treatment for control of Vibrio harveyi, a causal agent of luminous disease in Black tiger shrimp, anti-V. harveyi IgY was produced and showed its potential in our preliminary study. However, for further use as feed additive, the IgY stability should be evaluated. The titre of specific IgY was enhanced with an immunostimulant, C-phosphate guanosine oligodeoxynucleotide (CpG-ODN). IgY was stable at natural pH while the activity was decreased below pH 4 or above pH 10. The supplementation of 30% sorbitol significantly enhanced the IgY stability at tested temperatures in excess of 70°C. The activity of IgY remained at 9 and 94% after 4 h incubation in simulated gastric and intestinal fluids, respectively. A storage temperature at −20°C was found to be the best condition. IgY at the concentrations of 1, 5 and 10 mg/ml efficiently inhibited V. harveyi in vitro within 24 h after exposure.
- 1 September 2013
- Published by Taylor & Francis in Food and Agricultural Immunology
- Vol. 24 (3) , 279-294
Open AccessThe production of anti-Vibrio harveyiegg yolk immunoglobulin and evaluation of its stability and neutralisation efficacy
In order to replace the antibiotic treatment for control of Vibrio harveyi, a causal agent of luminous disease in Black tiger shrimp, anti-V. harveyi IgY was produced and showed its potential in our preliminary study. However, for further use as feed additive, the IgY stability should be evaluated. The titre of specific IgY was enhanced with an immunostimulant, C-phosphate guanosine oligodeoxynucleotide (CpG-ODN). IgY was stable at natural pH while the activity was decreased below pH 4 or above pH 10. The supplementation of 30% sorbitol significantly enhanced the IgY stability at tested temperatures in excess of 70°C. The activity of IgY remained at 9 and 94% after 4 h incubation in simulated gastric and intestinal fluids, respectively. A storage temperature at −20°C was found to be the best condition. IgY at the concentrations of 1, 5 and 10 mg/ml efficiently inhibited V. harveyi in vitro within 24 h after exposure.
- 25 June 2009
- Published by Springer Nature in Molecular Biology Reports
- Vol. 37 (4) , 1677-1683
Efficient amplification of light and heavy chain variable regions and construction of a non-immune phage scFv library
- 25 June 2009
- Published by Springer Nature in Molecular Biology Reports
- Vol. 37 (4) , 1677-1683
Efficient amplification of light and heavy chain variable regions and construction of a non-immune phage scFv library